Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Nothing else this week.
-
Millennium Management
alternative investment management firm
Nothing else this week.
-
Bank of America
American multinational banking and financial services corporation
Related events
- Jefferies Financial Group raised its shares to strong-buy rating, while Citigroup raised its shares to outperform rating, and Norges Bank bought a new position in Essex Property Trust, Inc.
- Acadia Pharmaceuticals reported revenue growth driven by product launches and market penetration.
- Morgan Stanley provides research coverage on Harmony Gold, a company based in South Africa, regarding a new investment purchase by a bank.
- Morgan Stanley analysis coincided with Alphabet's stock drop following poor earnings and a suspected crypto hack triggering asset freezes.
- Morgan Stanley provided analyst ratings and price targets for Steel Dynamics, whose stock trades on NASDAQ.